The following is a product information leaflet from Glaxo Smith Kline, the producer of the H1N1 vaccine:
http://www.gsk.ca/english/docs-pdf/A..._CAPA01v01.pdf

There is currently limited clinical experience with Arepanrix™ H1N1, and limited clinical experience with an investigational formulation of another AS03-adjuvanted vaccine containing the same or a slightly higher amount of antigen derived from A/California/7/2009 (H1N1) (see section Pharmacodynamics) in healthy adults aged 18-60 years and no clinical experience yet in the elderly, in children or in adolescents.
...Yet, the Canadian Government recommends that this vaccine should be taken by everyone over the age of 6 months.

Overblown hysteria?
Governments pushing vaccines that they shouldn't?
Have your say.